132 related articles for article (PubMed ID: 38423049)
1. Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
McPhail S; Barclay ME; Swann R; Johnson SA; Alvi R; Barisic A; Bucher O; Creighton N; Denny CA; Dewar RA; Donnelly DW; Dowden JJ; Downie L; Finn N; Gavin AT; Habbous S; Huws DW; Kumar SE; May L; McClure CA; Morrison DS; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Shack L; Tian X; Thomas RJ; Wang H; Woods RR; You H; Zhang B; Lyratzopoulos G;
Lancet Oncol; 2024 Mar; 25(3):352-365. PubMed ID: 38423049
[TBL] [Abstract][Full Text] [Related]
2. Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
McPhail S; Barclay ME; Johnson SA; Swann R; Alvi R; Barisic A; Bucher O; Creighton N; Denny CA; Dewar RA; Donnelly DW; Dowden JJ; Downie L; Finn N; Gavin AT; Habbous S; Huws DW; May L; McClure CA; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Shack L; Tian X; Thomas RJS; Thomson CS; Wang H; Woods RR; You H; Lyratzopoulos G;
Lancet Oncol; 2024 Mar; 25(3):338-351. PubMed ID: 38423048
[TBL] [Abstract][Full Text] [Related]
3. Risk factors and prognostic implications of diagnosis of cancer within 30 days after an emergency hospital admission (emergency presentation): an International Cancer Benchmarking Partnership (ICBP) population-based study.
McPhail S; Swann R; Johnson SA; Barclay ME; Abd Elkader H; Alvi R; Barisic A; Bucher O; Clark GRC; Creighton N; Danckert B; Denny CA; Donnelly DW; Dowden JJ; Finn N; Fox CR; Fung S; Gavin AT; Gomez Navas E; Habbous S; Han J; Huws DW; Jackson CGCA; Jensen H; Kaposhi B; Kumar SE; Little AL; Lu S; McClure CA; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Te Marvelde L; Thomas RS; Thomas RJS; Thomson CS; Woods RR; Zhang B; Lyratzopoulos G;
Lancet Oncol; 2022 May; 23(5):587-600. PubMed ID: 35397210
[TBL] [Abstract][Full Text] [Related]
4. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995-2014 (ICBP SURVMARK-2): a population-based study.
Arnold M; Rutherford MJ; Bardot A; Ferlay J; Andersson TM; Myklebust TÅ; Tervonen H; Thursfield V; Ransom D; Shack L; Woods RR; Turner D; Leonfellner S; Ryan S; Saint-Jacques N; De P; McClure C; Ramanakumar AV; Stuart-Panko H; Engholm G; Walsh PM; Jackson C; Vernon S; Morgan E; Gavin A; Morrison DS; Huws DW; Porter G; Butler J; Bryant H; Currow DC; Hiom S; Parkin DM; Sasieni P; Lambert PC; Møller B; Soerjomataram I; Bray F
Lancet Oncol; 2019 Nov; 20(11):1493-1505. PubMed ID: 31521509
[TBL] [Abstract][Full Text] [Related]
5. Changes in colorectal cancer incidence in seven high-income countries: a population-based study.
Araghi M; Soerjomataram I; Bardot A; Ferlay J; Cabasag CJ; Morrison DS; De P; Tervonen H; Walsh PM; Bucher O; Engholm G; Jackson C; McClure C; Woods RR; Saint-Jacques N; Morgan E; Ransom D; Thursfield V; Møller B; Leonfellner S; Guren MG; Bray F; Arnold M
Lancet Gastroenterol Hepatol; 2019 Jul; 4(7):511-518. PubMed ID: 31105047
[TBL] [Abstract][Full Text] [Related]
6. Time intervals and routes to diagnosis for lung cancer in 10 jurisdictions: cross-sectional study findings from the International Cancer Benchmarking Partnership (ICBP).
Menon U; Vedsted P; Zalounina Falborg A; Jensen H; Harrison S; Reguilon I; Barisic A; Bergin RJ; Brewster DH; Butler J; Brustugun OT; Bucher O; Cairnduff V; Gavin A; Grunfeld E; Harland E; Kalsi J; Knudsen AK; Lambe M; Law RJ; Lin Y; Malmberg M; Turner D; Neal RD; White V; Weller D
BMJ Open; 2019 Nov; 9(11):e025895. PubMed ID: 31776134
[TBL] [Abstract][Full Text] [Related]
7. Population-based cancer staging for oesophageal, gastric, and pancreatic cancer 2012-2014: International Cancer Benchmarking Partnership SurvMark-2.
Cabasag CJ; Arnold M; Piñeros M; Morgan E; Brierley J; Hofferkamp J; Kehoe S; Butler J; Bucher O; Bray F; Soerjomataram I; Parkin DM
Int J Cancer; 2021 Sep; 149(6):1239-1246. PubMed ID: 33990959
[TBL] [Abstract][Full Text] [Related]
8. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2).
Allemani C; Weir HK; Carreira H; Harewood R; Spika D; Wang XS; Bannon F; Ahn JV; Johnson CJ; Bonaventure A; Marcos-Gragera R; Stiller C; Azevedo e Silva G; Chen WQ; Ogunbiyi OJ; Rachet B; Soeberg MJ; You H; Matsuda T; Bielska-Lasota M; Storm H; Tucker TC; Coleman MP;
Lancet; 2015 Mar; 385(9972):977-1010. PubMed ID: 25467588
[TBL] [Abstract][Full Text] [Related]
9. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data.
Coleman MP; Forman D; Bryant H; Butler J; Rachet B; Maringe C; Nur U; Tracey E; Coory M; Hatcher J; McGahan CE; Turner D; Marrett L; Gjerstorff ML; Johannesen TB; Adolfsson J; Lambe M; Lawrence G; Meechan D; Morris EJ; Middleton R; Steward J; Richards MA;
Lancet; 2011 Jan; 377(9760):127-38. PubMed ID: 21183212
[TBL] [Abstract][Full Text] [Related]
10. Explaining variation in cancer survival between 11 jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey.
Rose PW; Rubin G; Perera-Salazar R; Almberg SS; Barisic A; Dawes M; Grunfeld E; Hart N; Neal RD; Pirotta M; Sisler J; Konrad G; Toftegaard BS; Thulesius H; Vedsted P; Young J; Hamilton W; ;
BMJ Open; 2015 May; 5(5):e007212. PubMed ID: 26017370
[TBL] [Abstract][Full Text] [Related]
11. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
12. Colon and rectal cancer survival in seven high-income countries 2010-2014: variation by age and stage at diagnosis (the ICBP SURVMARK-2 project).
Araghi M; Arnold M; Rutherford MJ; Guren MG; Cabasag CJ; Bardot A; Ferlay J; Tervonen H; Shack L; Woods RR; Saint-Jacques N; De P; McClure C; Engholm G; Gavin AT; Morgan E; Walsh PM; Jackson C; Porter G; Møller B; Bucher O; Eden M; O'Connell DL; Bray F; Soerjomataram I
Gut; 2021 Jan; 70(1):114-126. PubMed ID: 32482683
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic pathways for breast cancer in 10 International Cancer Benchmarking Partnership (ICBP) jurisdictions: an international comparative cohort study based on questionnaire and registry data.
Vedsted P; Weller D; Zalounina Falborg A; Jensen H; Kalsi J; Brewster D; Lin Y; Gavin A; Barisic A; Grunfeld E; Lambe M; Malmberg M; Turner D; Harland E; Hawryluk B; Law RJ; Neal RD; White V; Bergin R; Harrison S; Menon U; ;
BMJ Open; 2022 Dec; 12(12):e059669. PubMed ID: 36521881
[TBL] [Abstract][Full Text] [Related]
14. Impact of variation in cancer registration practice on observed international cancer survival differences between International Cancer Benchmarking Partnership (ICBP) jurisdictions.
Eden M; Harrison S; Griffin M; Lambe M; Pettersson D; Gavin A; Brewster DH; Lin Y; Johannesen TB; Milne RL; Farrugia H; Nishri D; King MJ; Huws DW; Warlow J; Turner D; Earle CC; Peake M; Rashbass J
Cancer Epidemiol; 2019 Feb; 58():184-192. PubMed ID: 30639877
[TBL] [Abstract][Full Text] [Related]
15. The International Cancer Benchmarking Partnership: an international collaboration to inform cancer policy in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom.
Butler J; Foot C; Bomb M; Hiom S; Coleman M; Bryant H; Vedsted P; Hanson J; Richards M;
Health Policy; 2013 Sep; 112(1-2):148-55. PubMed ID: 23693117
[TBL] [Abstract][Full Text] [Related]
16. Surgical treatment and survival from colorectal cancer in Denmark, England, Norway, and Sweden: a population-based study.
Benitez Majano S; Di Girolamo C; Rachet B; Maringe C; Guren MG; Glimelius B; Iversen LH; Schnell EA; Lundqvist K; Christensen J; Morris M; Coleman MP; Walters S
Lancet Oncol; 2019 Jan; 20(1):74-87. PubMed ID: 30545752
[TBL] [Abstract][Full Text] [Related]
17. A chronological map of 308 physical and mental health conditions from 4 million individuals in the English National Health Service.
Kuan V; Denaxas S; Gonzalez-Izquierdo A; Direk K; Bhatti O; Husain S; Sutaria S; Hingorani M; Nitsch D; Parisinos CA; Lumbers RT; Mathur R; Sofat R; Casas JP; Wong ICK; Hemingway H; Hingorani AD
Lancet Digit Health; 2019 Jun; 1(2):e63-e77. PubMed ID: 31650125
[TBL] [Abstract][Full Text] [Related]
18. [SENTIERI - Epidemiological Study of Residents in National Priority Contaminated Sites. Sixth Report].
Zona A; Fazzo L; Benedetti M; Bruno C; Vecchi S; Pasetto R; Minichilli F; De Santis M; Nannavecchia AM; Di Fonzo D; Contiero P; Ricci P; Bisceglia L; Manno V; Minelli G; Santoro M; Gorini F; Ancona C; Scondotto S; Soggiu ME; Scaini F; Beccaloni E; Marsili D; Villa MF; Maifredi G; Magoni M; Iavarone I;
Epidemiol Prev; 2023; 47(1-2 Suppl 1):1-286. PubMed ID: 36825373
[TBL] [Abstract][Full Text] [Related]
19. An International Consensus on Actions to Improve Lung Cancer Survival: A Modified Delphi Method Among Clinical Experts in the International Cancer Benchmarking Partnership.
Lynch C; Harrison S; Butler J; Baldwin DR; Dawkins P; van der Horst J; Jakobsen E; McAleese J; McWilliams A; Redmond K; Swaminath A; Finley CJ
Cancer Control; 2022; 29():10732748221119354. PubMed ID: 36269109
[TBL] [Abstract][Full Text] [Related]
20. Palliative radiotherapy after oesophageal cancer stenting (ROCS): a multicentre, open-label, phase 3 randomised controlled trial.
Adamson D; Byrne A; Porter C; Blazeby J; Griffiths G; Nelson A; Sewell B; Jones M; Svobodova M; Fitzsimmons D; Nixon L; Fitzgibbon J; Thomas S; Millin A; Crosby T; Staffurth J; Hurt C
Lancet Gastroenterol Hepatol; 2021 Apr; 6(4):292-303. PubMed ID: 33610215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
